UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. __)*
Span-America Medical Systems, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
846 396 109
--------------------------------------------------------------------------------
(CUSIP Number)
James G. Lane, Jr.
Chief Executive Officer
2155 West Croft Circle
Spartanburg, SC 29302
864-585-3605
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
December 5, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box [ ].
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13D
CUSIP NO. 846 396 109 PAGE 2 OF 13
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
Synalloy Corporation 570426694
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5. CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e) [ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7. SOLE VOTING POWER
79,433
---------------------------------------------------------------------------
8. SHARED VOTING POWER
0
---------------------------------------------------------------------------
9. SOLE DISPOSITIVE POWER
79,433
---------------------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
0
---------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
79,433
--------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions ) [ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.17%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON (See Instructions)
CO
--------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 846 396 109 PAGE 3 OF 13
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
Metchem, Inc. 51-0373317
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5. CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e) [ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7. SOLE VOTING POWER
79,433
---------------------------------------------------------------------------
8. SHARED VOTING POWER
0
---------------------------------------------------------------------------
9. SOLE DISPOSITIVE POWER
79,433
---------------------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
0
---------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
79,433
--------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions) [ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.17%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON (See Instructions)
CO
--------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 846 396 109 PAGE 4 OF 13
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
James G. Lane, Jr.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
5. CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e) [ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7. SOLE VOTING POWER
18,000
---------------------------------------------------------------------------
8. SHARED VOTING POWER
79,433
---------------------------------------------------------------------------
9. SOLE DISPOSITIVE POWER
18,000
---------------------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
79,433
---------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
97,433
--------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions) [ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.89%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON (See Instructions)
IN
--------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 846 396 109 PAGE 5 OF 13
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
Carroll D. Vinson
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
5. CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e) [ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7. SOLE VOTING POWER
45,600
---------------------------------------------------------------------------
8. SHARED VOTING POWER
79,433
---------------------------------------------------------------------------
9. SOLE DISPOSITIVE POWER
45,600
---------------------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
79,433
---------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
125,033
--------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions) [ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.99%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON (See Instructions)
IN
--------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 846 396 109 PAGE 6 OF 13
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
Glenn R. Oxner
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
5. CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e) [ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7. SOLE VOTING POWER
10,000
---------------------------------------------------------------------------
8. SHARED VOTING POWER
79,433
---------------------------------------------------------------------------
9. SOLE DISPOSITIVE POWER
10,000
---------------------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
79,433
---------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
89,433
--------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions) [ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.57%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON (See Instructions)
IN
--------------------------------------------------------------------------------
<PAGE>
PAGE 7 OF 13
Item 1. Security and Issuer
(i) Title of Class of Equity Securities to which this Statement relates: Common
Stock
(ii) Name and Address of Principal Executive Offices of Issuer: Span-America
Medical Systems, Inc., 70 Commerce Drive, Greenville, SC 29615 (hereinafter
referred to as the "Company" or "Issuer").
Item 2. Identity and Background
(a)-(c) This statement is being filed on behalf of Synalloy Corporation
("Synalloy"), Metchem, Inc., James G. Lane, Jr., Carroll D.
Vinson, and Glenn R. Oxner (collectively, the "Reporting
Persons").
Synalloy's principal business is metals and chemicals and its
principal place of business and offices are located at 2155 West
Croft Circle, Spartanburg, SC 29302.
Metchem, Inc. is a passive investment company and its principal
place of business and offices are located at 300 Delaware Avenue,
Suite 900, Wilmington, DE 19801. Metchem, Inc., is a wholly owned
subsidiary of Synalloy.
James G. Lane, Jr. has served as Chairman and Chief Executive
Officer of Synalloy since 1987. His business address is 2155 West
Croft Circle, Spartanburg, SC 29302.
Carroll D. Vinson is owner of C. D. Vinson & Associates, a
consulting firm, and a principal in VH, LLC, a privately owned
real estate investment company. His business address is
P. O. Box 5627, Spartanburg, SC 29304.
Glenn R. Oxner is Chairman and Chief Executive Officer of Edgar
M. Norris Co., Inc., an investment securities company in
Greenville, SC. His busines address is P. O. Box 434, Greenville,
SC 29602.
Each of Messrs. Lane, Vinson and Oxner is a director of Synalloy.
The only other director of Synalloy is Sibyl N. Fishburn. The
other executive officers of Synalloy are Ronald H. Braam, Joseph
N. Avento, Ronald L. Matthews and Gregory M. Bowie.
Sibyl N. Fishburn serves on the Board of the Virginia Nature
Conservancy. Her business address is P. O. Box 5627, Spartanburg,
SC 29304.
Ronald H. Braam is President of Manufacturers Chemicals, LP, a
wholly-owned subsidiary of Synalloy. His business address is P.
O. Box 2788, Cleveland, TN 37320-2788.
Joseph N. Avento is President of Bristol Metals, L.P., a
wholly-owned subsidiary of Synalloy. His business address is
P. O. Box 1589, Bristol, TN 37621.
Ronald L. Matthews is President of Blackman Uhler Chemical Co., a
division of Synalloy. His business address is P. O. Box 5627,
Spartanburg, SC 29304.
Gregory M. Bowie is Vice President, Finance, of Synalloy. His
business address is 2155 West Croft Circle, Spartanburg, SC
29302.
The executive officers and directors of Metchem, Inc. are James
G. Lane, Jr., Gregory M. Bowie and Linda S. Bubacz.
Ms. Bubacz is Secretary and Assistant Treasurer of Metchem, Inc.,
and her business address is 300 Delaware Avenue, Suite 900,
Wilmington, DE 19801.
<PAGE>
PAGE 8 OF 13
(d),(e) During the last five years, none of the Reporting Persons, nor
any director or executive officer of Synalloy or Metchem, Inc.
listed above (i) has been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors) or (ii)
has been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of
such proceeding was or is subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or
finding any violation with respect to such laws.
(f) Each of Messrs. Lane, Vinson and Oxner and each director and
executive officer of Synalloy and Metchem, Inc. named above is a
citizen of the United States.
Item 3. Source and Amount of Funds or Other Consideration
The shares of Common Stock of the Company held by Synalloy/Metchem, Inc. were
acquired in open market purchases from September 1, 2000 to December 15, 2000,
at an aggregate purchase price of approximately $318,043.50. The shares held by
Mr. Vinson were acquired in open market purchases from April 30, 1999 to January
3, 2000 at an aggregate purchase price of approximately $175,992. The shares
held by Mr. Lane were acquired in open market purchases from December 22, 1999
to August 24, 2000 at an aggregate purchase price of approximately $67,246. The
shares held by Mr. Oxner were acquired in open market purchases from July 23,
1993 to July 31, 1995 at an aggregate purchase price of approximately $50,172.
Such purchases were funded with working capital of Synalloy and personal funds
of the other Reporting Persons. None of the purchases made by the Reporting
Persons were funded with borrowed money.
Item 4. Purpose of Transaction
The Shares have been acquired by the Reporting Persons with a view to ultimately
acquiring control of the Company pursuant to a merger with, or acquisition of
additional stock by, Synalloy or one of its subsidiaries. Such merger or
acquisition would likely result in changes to the present Board of Directors and
management of the Company, and might result in changes in the Company's
capitalization and dividend policy, business, corporate structure and governing
documents. The nature of any such changes has not yet been determined.
Additionally, such a transaction would likely result in the Company's common
stock ceasing to be quoted in an inter-dealer quotation system and in
termination of the Company's registration under Section 12(g)(4) of the
Securities Exchange Act of 1934.
Synalloy has contacted the Chairman of the Board of the Company and expressed an
interest in acquiring the Company and expects to have further discussions with
management of the Company.
The Reporting Persons reserve the right to acquire additional shares of the
Company and/or to dispose of all or part of their holdings.
Item 5. Interest in Securities of the Issuer
(a) Synalloy indirectly owns the 79,433 Shares of Common Stock owned by
its subsidiary, Metchem, Inc., which constitutes approximately 3.17%
of the Company's outstanding Shares of Common Stock.
Mr. Lane owns 18,000 shares of Common Stock. Mr. Lane may be
considered the beneficial owner of the 79,433 shares of the Common
Stock beneficially owned by Synalloy, as to which shares Mr. Lane
disclaims beneficial ownership, representing in the aggregate 3.89% of
the Company's outstanding shares of Common Stock.
Mr. Vinson owns 45,600 shares of Common Stock. Mr. Vinson may be
considered the beneficial owner of the 79,433 shares of the Common
Stock beneficially owned by Synalloy, as to which shares Mr. Vinson
disclaims beneficial ownership, representing in the aggregate 4.99% of
the Company's outstanding shares of Common Stock.
Mr. Oxner owns 10,000 shares of Common Stock. Mr. Oxner may be
considered the beneficial owner of the 79,433 shares of the Common
Stock beneficially owned by Synalloy, as to which shares Mr. Oxner
disclaims beneficial ownership, representing in the aggregate 3.57% of
the Company's outstanding shares of Common Stock.
None of the other executive officers or directiors of Synalloy or
Metchem, Inc. owns any shares of the Company's Common Stock.
<PAGE>
PAGE 9 OF 13
All of the above calculations are based on outstanding share
information derived from the Company's Form 10-Q for the quarter ended
September 30, 2000.
(b) Synalloy, as sole shareholder of Metchem, Inc., has the sole power to
vote and the sole power to dispose of 79,433 Shares of Common Stock.
Messrs. Lane, Vinson and Oxner, as the directors and officers of
Synalloy, may be deemed to have shared power to vote and shared power
to dispose of the shares held by Synalloy.
Mr. Lane has the sole power to vote and the sole power to dispose of
18,000 Shares of Common Stock.
Mr. Vinson has the sole power to vote and the sole power to dispose of
45,600 Shares of Common Stock.
Mr. Oxner has the sole power to vote and the sole power to dispose of
10,000 Shares of Common Stock.
(c) Metchem has made the following purchases of the Company's stock in the
past 60 days:
Transaction Number of Price Total
Date Shares Per Share Cost
---- ------ --------- ----
10/6/00 5,033 3 7/8 19,502.88
10/13/00 11,200 3 7/8 43,400.00
11/13/00 8,200 4 11/64 34,209.38
11/20/00 3,500 3 15/16 13,781.25
11/24/00 1,000 4 4,000.00
11/27/00 2,000 3 15/16 7,875.00
12/5/00 23,300 4 93,200.00
12/14/00 4,800 4 19,200.00
------ ------- ----------
Total 59,033 3.984 235,168.51
All of such purchases were made in broker's transactions.
<PAGE>
PAGE 10 OF 13
There were no other purchases or sales of shares of the Company's
Common Stock by the Reporting Persons or the other directors or
executive officers of Synalloy or Metchem, Inc. in the past 60 days.
(d) No other person is known by any Reporting Person to have the right to
receive or the power to direct the receipt of dividends from, or the
proceeds from the sale of, any Shares beneficially owned by any
Reporting Person.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer.
To the extent that Shares owned by the Reporting Persons may be held
in a margin account, they may be pledged along with other positions in
such accounts as collateral security for the repayment of debit
balances in the account. Because other securities are held in such
accounts, however, it is not possible to determine the amount, if any,
of margin used by the Reporting Persons with respect to the Shares.
Item 7. Material to Be Filed as Exhibits
(a) Copy of the written agreement relating to the filing of joint
acquisition statements.
(b) Power of Attorney.
<PAGE>
PAGE 11 OF 13
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date: December 15, 2000
------------------
SYNALLOY CORPORATION
By:/s/James G. Lane, Jr.
---------------------------------------------
Name: James G. Lane, Jr.
-------------------------------------------
Title: Chairman and Chief Executive Officer
------------------------------------------
METCHEM, INC.
By:/s/James G. Lane, Jr.
---------------------------------------------
Name: James G. Lane, Jr.
-------------------------------------------
Title: Chairman and Chief Executive Officer
------------------------------------------
/s/James G. Lane, Jr.
------------------------------------------------
James G. Lane, Jr.
/s/Carroll D. Vinson
------------------------------------------------
Carroll D. Vinson
/s/Glenn R. Oxner
------------------------------------------------
Glenn R. Oxner
<PAGE>
PAGE 12 OF 13
Exhibit (a)
AGREEMENT TO FILE SCHEDULES 13D JOINTLY
Pursuant to the requirements of Rule 13d-1(k)(1)(iii), the undersigned
hereby agree that whenever one or more of them is required to file a statement
containing the information required by Schedule 13D (or an amendment thereto)
relating to shares of Span-America Medical Systems, Inc., which Schedule 13D
relates as to each of them to the same securities, they agree that only one such
statement shall be filed on behalf of all such persons containing the required
information with regard to each such person.
Dated this 15th day of December, 2000.
Synalloy Corporation
/s/James G. Lane, Jr.
By:-----------------------------------------
Its President and Chief Executive Officer
METCHEM, INC.
By:/s/James G. Lane, Jr.
---------------------------------------------
Name: James G. Lane, Jr.
-------------------------------------------
Title: Chairman and Chief Executive Officer
------------------------------------------
/s/James G. Lane, Jr.
--------------------------------------------
James G. Lane, Jr.
/s/Carroll D. Vinson
--------------------------------------------
Carroll D. Vinson
/s/Glenn R. Oxner
--------------------------------------------
Glenn R. Oxner
<PAGE>
PAGE 13 OF 13
Exhibit (b)
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each of Synalloy Corporation, Metchem,
Inc., Carroll D. Vinson and Glenn R. Oxner, hereby makes, constitutes and
appoints James G. Lane, Jr., its and his true and lawful attorney, with full
power of substitution, to execute, deliver and file in its or his name and on
its or his behalf, with the Securities and Exchange Commission (the
"Commission") reports (and amendments and supplements thereto) relating to
beneficial ownership of securities in Span-America Medical Systems, Inc. on
Forms 3, 4 and 5 and Schedule 13D under the Securities Exchange Act of 1934, and
on such other forms as may be promulgated from time to time by the Commission;
and each of Synalloy Corporation, Metchem, Inc., Carroll D. Vinson and Glenn R.
Oxner , grants to said attorney, full power and authority to do and perform each
and every act and thing whatsoever as said attorney may deem necessary or
advisable to carry out fully the intent of this power of attorney to the same
extent and with the same effect as Synalloy Corporation and Metchem, Inc. might
or could do, and as each of said individuals might or could do personally, and
each of Synalloy Corporation, Metchem, Inc., and such individuals hereby
ratifies and confirms all acts and things which said attorney might do or cause
to be done by virtue of this power of attorney and its or his signatures as the
same may be signed by said attorney, to any or all of the following (and/or any
and all amendments and supplements to any or all thereof): Forms 3, 4 and 5 and
Schedule 13D and any other forms promulgated by the Commission for the purpose
of reporting beneficial ownership or changes in beneficial ownership of
securities, with respect to securities owned or hereafter acquired by any or all
of them in Span-America Medical Systems, Inc.
IN WITNESS WHEREOF, each of Synalloy Corporation and Metchem, Inc., has
caused this power of attorney to be signed on its behalf, and each of the
undersigned has hereunto set his hand, as of the dates indicated below.
Synalloy Corporation
December 15, 2000 /s/James G. Lane, Jr.
By:------------------------------------------
Its President and Chief Executive Officer
METCHEM, INC.
By:/s/James G. Lane, Jr.
---------------------------------------------
Its: Chairman and Chief Executive Officer
---------------------------------------------
/s/Carroll D. Vinson
----------------------------------------
Carroll D. Vinson
/s/Glenn R. Oxner
----------------------------------------
Glenn R. Oxner
